Scholarlink

<p>Sporadic cerebral amyloid angiopathy (CAA) is a small-vessel disease. We sought to assess pathological findings and outcomes in CAA patients with non-traumatic intracerebral lobe hemorrhage (ICH). Sixty-three CAA-ICH patients underwent Hematoxylin-eosin, amyloid-β, smooth muscle actin, and CD34 staining. Arterioles were graded using a CAA-severity scale. Prospective ≥ 12-month follow-up identified prognostic factors via Spearman correlation analysis and binary logistic regression. Cox proportional hazard regression models assessed mortality or recurrent ICH risk associations. Among 93 Chinese ICH patients, 63 (67.7%) were diagnosed with CAA. Pathological grading showed Grade 1: 8 (12.7%), Grade 2: 12 (19.0%), Grade 3–4: 43 (68.3%). The median preoperative hematoma volumes in patients with Grade 1, Grade 2, and Grades 3–4 CAA were 42&#xa0;mL (30–53), 50&#xa0;mL (41–60), and 55&#xa0;mL (48–89), respectively (<i>p</i> = 0.016). Among 32 CAA patients with available cortical specimens, 23 (71.9%) exhibited dense-core plaques and 26 (81.3%) showed diffuse plaques. Dense-core plaques were observed predominantly in moderate-to-severe (Grades 2–4) CAA. Cortical superficial siderosis (cSS) moderately correlated with CAA severity (R = 0.528, <i>p</i> = 0.006). After adjusting for age, sex, antiplatelet therapy, and alcohol abuse, CAA severity predicted 1-year mortality (adjusted odds ratio [OR] = 18.49; 95% confidence interval [CI], 1.78–193.03; <i>p</i> = 0.015). Both CAA severity and age predicted mortality or recurrent ICH risk (adjusted hazard ratio [HR] = 4.16; 95% CI, 1.54–11.24; <i>p</i> = 0.005; and adjusted HR = 1.08; 95% CI, 1.02–1.14; <i>p</i> = 0.008, respectively). CAA severity also independently predicted the risk of recurrent ICH (adjusted HR = 5.65; 95% CI, 1.25–25.62; <i>p</i> = 0.025). Most CAA-ICH patients had moderate-to-severe CAA in cortico-leptomeningeal regions. Cortical biopsies revealed frequent amyloid-β (Aβ) deposition in dense-core and diffuse plaques, with dense-core plaques predominating in moderate-to-severe CAA. CAA severity correlated with long-term outcomes in CAA-ICH.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Pathological findings from surgical specimens and long-term outcome in cerebral amyloid angiopathy patients with intracerebral hemorrhage

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月27日

查看全文
  • Feng Liu,
  • Jia Liu,
  • Hao Wu,
  • Pan Wang,
  • Shuai Liu,
  • Zihan Wang,
  • Xuebin Zhang,
  • Shumei Jin,
  • Yong Ji,
  • Xiaoling Yan,
  • Zhihong Shi

摘要

Sporadic cerebral amyloid angiopathy (CAA) is a small-vessel disease. We sought to assess pathological findings and outcomes in CAA patients with non-traumatic intracerebral lobe hemorrhage (ICH). Sixty-three CAA-ICH patients underwent Hematoxylin-eosin, amyloid-β, smooth muscle actin, and CD34 staining. Arterioles were graded using a CAA-severity scale. Prospective ≥ 12-month follow-up identified prognostic factors via Spearman correlation analysis and binary logistic regression. Cox proportional hazard regression models assessed mortality or recurrent ICH risk associations. Among 93 Chinese ICH patients, 63 (67.7%) were diagnosed with CAA. Pathological grading showed Grade 1: 8 (12.7%), Grade 2: 12 (19.0%), Grade 3–4: 43 (68.3%). The median preoperative hematoma volumes in patients with Grade 1, Grade 2, and Grades 3–4 CAA were 42 mL (30–53), 50 mL (41–60), and 55 mL (48–89), respectively (p = 0.016). Among 32 CAA patients with available cortical specimens, 23 (71.9%) exhibited dense-core plaques and 26 (81.3%) showed diffuse plaques. Dense-core plaques were observed predominantly in moderate-to-severe (Grades 2–4) CAA. Cortical superficial siderosis (cSS) moderately correlated with CAA severity (R = 0.528, p = 0.006). After adjusting for age, sex, antiplatelet therapy, and alcohol abuse, CAA severity predicted 1-year mortality (adjusted odds ratio [OR] = 18.49; 95% confidence interval [CI], 1.78–193.03; p = 0.015). Both CAA severity and age predicted mortality or recurrent ICH risk (adjusted hazard ratio [HR] = 4.16; 95% CI, 1.54–11.24; p = 0.005; and adjusted HR = 1.08; 95% CI, 1.02–1.14; p = 0.008, respectively). CAA severity also independently predicted the risk of recurrent ICH (adjusted HR = 5.65; 95% CI, 1.25–25.62; p = 0.025). Most CAA-ICH patients had moderate-to-severe CAA in cortico-leptomeningeal regions. Cortical biopsies revealed frequent amyloid-β (Aβ) deposition in dense-core and diffuse plaques, with dense-core plaques predominating in moderate-to-severe CAA. CAA severity correlated with long-term outcomes in CAA-ICH.